What is BioSig Technologies, Inc.'s stock-based comp?

BioSig Technologies, Inc. (STEX) reported stock-based comp of $25.37M in Q1 2026.

How has BioSig Technologies, Inc.'s stock-based comp changed year-over-year?

BioSig Technologies, Inc.'s stock-based comp increased by 1123.2% year-over-year, from $2.07M to $25.37M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

BioSig Technologies, Inc. STEX Stock-Based Comp

Stock-Based Comp at other companies

Tradeweb Markets Inc.TW

$25.06M+12.9%

Bit DigitalBTBT

$15.3M+5,964%

Scilex Holding CompanySCLX

$3.63M+9.5%

DigitalBridge GroupDBRG

$6.94M-2.9%

StoneX Group Inc.SNEX

$13.7M+28.0%

TEC

Bio-TechneTECH

$10.5M-7.9%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s stock-based comp?: BioSig Technologies, Inc. (STEX) reported stock-based comp of $25.37M in Q1 2026.
How has BioSig Technologies, Inc.'s stock-based comp changed year-over-year?: BioSig Technologies, Inc.'s stock-based comp increased by 1123.2% year-over-year, from $2.07M to $25.37M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.